article

Raman Spectroscopy: In-Depth Focus 2014

Posted: 5 November 2014 |

Sulaf Assi discusses the investigation of medicine quality using handheld Raman spectroscopy, a look at Raman hyperspectral imaging, plus Raman roundtable…

Raman In-Depth Focus 2014
  • Investigating the quality of medicines using handheld Raman spectroscopy
    Sulaf Assi, Associate Lecturer, Forensic Sciences, Bournemouth University
    Poor-quality medicines represent a potential public health threat ranging from ineffectiveness to, in the worst cases, death. Such medicines could be encountered anywhere which urges the need to find rapid and nondestructive methods for their identification. Handheld Raman spectroscopy offers a rapid, quick, non-destructive and mobile technique for medicines’ identification. Moreover, the Raman scattering is selective to active pharmaceutical ingredients (APIs); whereas excipients are often Raman-inactive…
  • Raman hyperspectral imaging: a single tool to characterise pharmaceutical products
    Lauranne Netchacovitch, Charlotte De Bleye, Pierre-François Chavez, Pierre-Yves Sacré, Philippe Hubert and Eric Ziemons, Scientists at Laboratory of Analytical Chemistry, CIRM, Department of Pharmacy, University of Liege
    Raman hyperspectral imaging is an increasingly used tool in the pharmaceutical field because it allows for the investigation of many characteristics on a solid sample. This paper delves into Raman spectroscopy and imaging, including spectral and spatial information, and presents some applications of Raman hyperspectral imaging in the pharmaceutical field…
  • Roundtable
    Moderator: Bradley Diehl, Manager – PAT Projects, Pfizer, Inc
    With contributions from Robert C. Brush (Business Development Manager, Thermo Scientific), Katherine A. Bakeev (Director – Application Support Services, B&W Tek), Richard Streamer (Business Development Manager, Rigaku), Andrew Owen (Applications Manager, Cobalt Light Systems)

This Raman Spectroscopy In-Depth Focus is restricted - login or subscribe free to access

EPR Issue 1 2024Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here